Clinical Trials Browser

Phase 3 × Endometrial Neoplasms × durvalumab × Clear all

NCT06746116 2026-01-16

DUoENDE

Phase 3 Active not recruiting

Endometrial Neoplasms

NCT04269200 2025-12-23

DUO-E

Phase 3 Active not recruiting

805 enrolled 18 charts 1 FDA

Endometrial Neoplasms